Endoscopic application of hemostatic thrombin-gelatin matrix (FloSeal®) in anticoagulated pigs

Minimally Invasive Therapy and Allied Technologies

Volumn 19, Issue 1, 2010, Pages 48-51

  Hammes, C ^a   Moersdorf, G ^b   Refeidi, A ^c   Post, S ^a   Kaehler, G ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Baxter Deutschland GmbH   (Germany)

^c KING KHALID UNIVERSITY   (Saudi Arabia)

Author keywords

Endoscopic hemostasis; FloSeal; Heparinization; Platelet aggregation inhibition; Upper gastrointestinal bleeding

Indexed keywords

HEMOGLOBIN; THROMBIN;

ARTICLE; CONTROLLED STUDY; GASTROINTESTINAL HEMORRHAGE; GEL; HEMOSTASIS; NONHUMAN; OPERATION DURATION; PRIORITY JOURNAL; RECURRENT DISEASE; SURGICAL TECHNIQUE; SWINE; THROMBOCYTE AGGREGATION INHIBITION;

ANIMALS; ANTICOAGULANTS; ASPIRIN; BLOOD COAGULATION DISORDERS; DISEASE MODELS, ANIMAL; ENDOSCOPY; GASTROINTESTINAL HEMORRHAGE; GELATIN SPONGE, ABSORBABLE; HEMOSTATICS; HEPARIN; LYSINE; PLATELET AGGREGATION INHIBITORS; SWINE;

EID: 76749093086     PISSN: 13645706     EISSN: 13652931     Source Type: Journal    
DOI: 10.3109/13645700903516585     Document Type: Article

References (17)

1. Ell C, Hagenmuller F, Schmitt W, Riemann JF, Hahn EG, Hohenberger W. [Multicenter prospective study of the current status of treatment for bleeding ulcer in Germany]. Dtsch Med Wochenschr 1995;120:3-9.
2. Elta GH. Acute Nonvariceal Upper Gastrointestinal Hemorrhage. Curr Treat Options Gastroenterol. 2002;5:147-152
3. Khuroo MS, Khuroo MS, Farahat KL, Kagevi IE. Treatment with proton pump inhibitors in acute non-variceal upper gastrointestinal bleeding: a meta-analysis. J Gastroenterol Hepatol. 2005;20:11-25.
4. Lau JY, Sung JJ, Lam YH, Chan AC, Ng EK, Lee DW, et al. Endoscopic retreatment compared with surgery in patients with recurrent bleeding after initial endoscopic control of bleeding ulcers. N Engl J Med. 1999;340:751-756
5. Nietsch H, Lotterer E, Fleig WE. [Acute upper gastrointestinal hemorrhage. Diagnosis and management]. Internist (Berl) 2003;44:519-528
6. Trevisani L, Chiamenti CM, Gaudenzi P, Sartori S, Pezzoli A, Gullini S, et al. [Endoscopic treatment of upper gastrointestinal non-variceal bleeding]. Minerva Med 2002;93: 129-134
7. Barada K, Abdul-Baki H, El H, II II, Hashash JG, Green PH. Gastrointestinal Bleeding in the Setting of Anticoagulation and Antiplatelet Therapy. J Clin Gastroenterol. 2008; 42:368-372
8. Bretagne JF. [Risk and prevention of gastrointestinal complications due to low-dose aspirin and other antiplatelet agents]. Rev Prat. 2008;58:1434-1436
9. Henriksen PA, Palmer K, Boon NA. Management of upper gastrointestinal haemorrhage complicating dual anti-platelet therapy. QJM 2008;101:261-267
10. Weickert U, Riemann JF. [The management of bleeding ulcers]. Internist (Berl) 2006;47:596-601.
11. Zullo A, Hassan C, Campo SM, Morini S. Bleeding peptic ulcer in the elderly: risk factors and prevention strategies. Drugs Aging 2007;24:815-828
12. Mathiasen RA, Cruz RM. Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in patients with acute anterior epistaxis. Laryngoscope 2005;115:899-902.
13. Miyamoto K, Masuda K, Inoue N, Okuma M, Muehlemann C, An HS. Anti-adhesion properties of a thrombin- based hemostatic gelatin in a canine laminectomy model: a biomechanical, biochemical, and histologic study. Spine 2006;31:E91-7.
14. Mongardini M, Pappalardo G. [The use of Floseal in the prevention and treatment of intra- and post-operative hemorrhage in the surgical treatment of hemorrhoids and colporectocele. Preliminary results]. G Chir 2003;24: 377-381
15. Oz MC, Cosgrove DM, 3rd, Badduke BR, Hill JD, Flannery MR, Palumbo R, et al. Controlled clinical trial of a novel hemostatic agent in cardiac surgery. The Fusion Matrix Study Group. Ann Thorac Surg. 2000;69:1376-1382
16. Zippi M, Febbraro I, De Felici I, Mattei E, Traversa G, Occhigrossi G. [Diagnosis and treatment of bleeding peptic ulcer: our experience.]. Clin Ter. 2008;159:249-255
17. Khurram Z, Chou E, Minutello R, Bergman G, Parikh M, Naidu S, Wong SC, Hong MK. Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding. J Invasive Cardiol. 2006; 18:162-164